Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain
07 mars 2024 03h00 HE
|
Persica Pharmaceuticals
Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held,...
Chronic Lower Back Pain Treatment Market Size [2022-2028] | Industry Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report
10 janv. 2022 04h51 HE
|
Fortune Business Insights
Pune, India, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The rising prevalence of chronic pain across the world is expected to drive the global chronic lower back pain treatment market. As per the National...
Researchers Unveil a New Theory Explaining Long-term Pain Relief
15 mars 2021 09h30 HE
|
SPR Therapeutics, Inc.
CLEVELAND, March 15, 2021 (GLOBE NEWSWIRE) -- A novel theory recently published in the Journal of Pain Research proposes mechanisms by which a 60-day treatment using percutaneous peripheral nerve...
SPRINT® PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA
02 mars 2021 10h45 HE
|
SPR Therapeutics, Inc.
CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of...
Back Pain Wizard Customer Review: Get Lower Back Pain Relief
23 nov. 2020 05h00 HE
|
Back Pain Wizard
New York City, NY , Nov. 23, 2020 (GLOBE NEWSWIRE) -- The Back Pain Wizard is a system designed to reinstate muscle balance by releasing the trapped tension in the back and stabilizing the right...
Scilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger Integration
05 juin 2019 07h00 HE
|
Sorrento Therapeutics, Inc.
ZTlido® gross sales grew from approximately $1 million in March to $2.4 million in April and $3.3 million in MaySP-102 pivotal phase 3 trial remains on track for completion in H1 2020ZTlido® 5.4% (3 X...
SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain
25 sept. 2018 10h10 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Christopher Gilmore, MD of Carolinas Pain...
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
16 août 2018 08h30 HE
|
SPR Therapeutics, Inc.
SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...
hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Medical Weight Loss Programs Geared Toward Relieving Lower Back Pain
30 juin 2014 07h00 HE
|
Diet Doc Weight Loss
ESCONDIDO, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Being overweight forces the spine to absorb an extra burden and causes thousands of Americans to suffer lower back pain. Over time, those who are...
POSITIVE SPINAL DISC REPAIR TRIAL RESULTS USING MESOBLAST ADULT STEM CELLS
29 janv. 2014 18h31 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced positive 12 month outcome results from the...